封面
市場調查報告書
商品編碼
1746891

日本家庭輸液治療市場報告(按產品、應用和地區)2025-2033

Japan Home Infusion Therapy Market Report by Product, Application, and Region 2025-2033

出版日期: | 出版商: IMARC | 英文 115 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

2024年,日本家庭輸液治療市場規模達26.85億美元。展望未來, IMARC Group預計到2033年,該市場規模將達到47.823億美元,2025-2033年期間的複合年成長率(CAGR)為6.6%。慢性病發病率的上升、家庭醫療保健需求的日益成長以及產品供應的持續改進是推動市場成長的主要因素。

居家輸液療法是一種專業的醫療手段,利用幫浦、導管和藥瓶等各種設備,在患者舒適的家中,透過靜脈注射方式為其輸送藥物(例如抗病毒藥物或免疫球蛋白)、液體或營養物質。這種療法適用於感染、癌症或患有多發性硬化症 (MS) 或類風濕性關節炎等慢性疾病且需要長期或頻繁輸液治療的患者。居家輸液療法帶來舒適便捷的體驗,提高病患的整體生活品質,並降低醫院內感染的風險。此外,它還能增強患者的能力,讓他們在接受必要的醫療照護的同時,保持獨立性和對自身治療的掌控感。居家輸液療法在多種治療中都特別有效,包括化療、補液、腸內給藥、正性肌力治療、抗感染治療、營養治療和疼痛管理等,常用於治療糖尿病以及各種胃腸道疾病和腫瘤疾病。

日本家庭輸液治療市場趨勢:

日本家庭輸液治療市場正經歷大幅成長,這得益於癌症、骨關節炎、人類免疫缺陷病毒 (HIV) 和糖尿病等慢性疾病盛行率的上升。老年人口的不斷成長,更容易患上需要定期就醫的危及生命的疾病,尤其是輸液治療,這也對市場成長做出了重大貢獻。此外,政府措施、優惠的報銷政策以及長期住院帶來的醫療費用上漲,都在激勵患者選擇家庭輸液治療,進一步推動了市場擴張。此外,由於家庭醫療保健服務便利且經濟高效,人們越來越傾向於選擇此類服務,再加上醫院資源日益緊張,也是另一個重要的成長誘因。此外,由於長期接觸受污染的設備、床單和空氣飛沫,醫院內獲得性感染 (HAI) 的增加也加劇了市場的擴張。對專科藥物的廣泛需求以及對專科用藥的需求,也為市場帶來了新的成長動力。此外,預計創新技術進步將在預測期內推動市場成長,例如開發配備先進滴灌系統的輕巧、便攜、方便用戶使用的輸液泵,用於精確即時監測靜脈注射治療。

日本家庭輸液治療市場區隔:

產品洞察:

  • 點滴幫浦
    • 彈性體
    • 機電
    • 重力
    • 其他
  • 靜脈輸液器
  • 靜脈插管
  • 無針頭連接器

應用程式洞察:

  • 抗感染
  • 內分泌學
    • 糖尿病
    • 其他
  • 水合療法
    • 運動員
    • 其他
  • 化療
  • 腸內營養
  • 腸外營養
  • 特種製藥
  • 其他

競爭格局:

市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀錶板和公司評估象限等競爭分析。此外,報告還提供了所有主要公司的詳細資料。

本報告回答的關鍵問題:

  • 日本家庭輸液治療市場迄今表現如何?未來幾年將如何表現?
  • COVID-19 對日本家庭輸液治療市場有何影響?
  • 日本家庭輸液治療市場依產品分類是怎樣的?
  • 日本家庭輸液治療市場如何根據應用情況分類?
  • 日本家庭輸液治療市場的價值鏈分為哪些階段?
  • 日本家庭輸液治療的主要促進因素和挑戰是什麼?
  • 日本家庭輸液治療市場的結構是怎麼樣的?主要參與者是誰?
  • 日本家庭輸液治療市場的競爭程度如何?

本報告回答的關鍵問題:

  • 日本家庭輸液治療市場迄今表現如何?未來幾年將如何表現?
  • COVID-19 對日本家庭輸液治療市場有何影響?
  • 日本家庭輸液治療市場依產品分類是怎樣的?
  • 日本家庭輸液治療市場如何根據應用情況分類?
  • 日本家庭輸液治療市場的價值鏈分為哪些階段?
  • 日本家庭輸液治療的主要促進因素和挑戰是什麼?
  • 日本家庭輸液治療市場的結構是怎麼樣的?主要參與者是誰?
  • 日本家庭輸液治療市場的競爭程度如何?

目錄

第1章:前言

第2章:範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章:執行摘要

第4章:日本家庭輸液治療市場 - 簡介

  • 概述
  • 市場動態
  • 產業趨勢
  • 競爭情報

第5章:日本家庭輸液治療市場格局

  • 歷史與當前市場趨勢(2019-2024)
  • 市場預測(2025-2033)

第6章:日本家庭輸液治療市場-細分:依產品

  • 點滴幫浦
    • 概述
    • 市場區隔
      • 彈性體
      • 機電
      • 重力
      • 其他
  • 靜脈輸液器
    • 概述
  • 靜脈插管
    • 概述
  • 無針頭連接器
    • 概述

第7章:日本家庭輸液治療市場-細分:依應用

  • 抗感染
    • 概述
  • 內分泌學
    • 概述
    • 市場區隔
      • 糖尿病
      • 其他
  • 水合療法
    • 概述
    • 市場區隔
      • 運動員
      • 其他
  • 化療
    • 概述
  • 腸內營養
    • 概述
  • 腸外營養
    • 概述
  • 特種製藥
    • 概述
  • 其他

第 8 章:日本家庭輸液治療市場 - 競爭格局

  • 概述
  • 市場結構
  • 市場參與者定位
  • 最佳獲勝策略
  • 競爭儀錶板
  • 公司評估象限

第9章:關鍵參與者簡介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 10 章:日本家庭輸液治療市場 - 產業分析

  • 促進因素、限制因素和機遇
    • 概述
    • 驅動程式
    • 限制
    • 機會
  • 波特五力分析
    • 概述
    • 買家的議價能力
    • 供應商的議價能力
    • 競爭程度
    • 新進入者的威脅
    • 替代品的威脅
  • 價值鏈分析

第 11 章:附錄

簡介目錄
Product Code: SR112025A19967

Japan home infusion therapy market size reached USD 2,685.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 4,782.3 Million by 2033, exhibiting a growth rate (CAGR) of 6.6% during 2025-2033. The growing incidence of chronic illnesses, the rising inclination towards home healthcare, and continuous advancements in product offerings are among the primary factors propelling the market growth.

Home infusion therapy is a specialized medical treatment that involves delivering medications, such as antivirals or immune globulin, fluids, or nutrition intravenously to patients in the comfort of their homes, utilizing various equipment like pumps, catheters, and vials. This form of therapy is recommended for individuals dealing with infections, cancer, or chronic conditions like multiple sclerosis (MS) or rheumatoid arthritis that necessitate long-term or frequent infusion treatment. Home infusion therapy provides a sense of comfort and convenience, enhances the overall quality of life, and diminishes the risk of hospital-acquired infections. Moreover, it empowers patients by allowing them to maintain a sense of independence and control over their treatment while still receiving essential medical care. Home infusion therapy is particularly effective in diverse treatments, including chemotherapy, hydration, enteral, inotropic, anti-infective, nutritional, and pain management therapies, commonly employed for conditions such as diabetes and various gastrointestinal and oncological disorders.

Japan Home Infusion Therapy Market Trends:

The Japan home infusion therapy market is witnessing substantial growth, driven by an increase in the prevalence of chronic diseases like cancer, osteoarthritis, human immunodeficiency viruses (HIV), and diabetes. The expanding geriatric population, more susceptible to life-threatening illnesses requiring regular medical attention, particularly infusion therapy, is also contributing significantly to market growth. Besides this, government initiatives, favorable reimbursement policies, and the rising costs associated with prolonged hospital stays are motivating patients to opt for home infusion therapy, further fueling market expansion. Additionally, the growing preference for home healthcare services due to their convenience and cost-effectiveness, coupled with the increasing strain on hospital resources, is acting as another significant growth-inducing factor. Apart from this, the rise in hospital-acquired infections (HAIs) due to prolonged exposure to contaminated equipment, bed linens, and air droplets is amplifying the market's expansion. The widespread demand for specialty drugs, necessitating specialized administration, adds another layer of growth to the market. Furthermore, innovative technological advancements, such as the development of lightweight, portable, and user-friendly infusion pumps equipped with advanced drip systems for precise and real-time monitoring of IV treatments, are anticipated to fuel the market growth over the forecasted period.

Japan Home Infusion Therapy Market Segmentation:

Product Insights:

  • Infusion Pumps
    • Elastomeric
    • Electromechanical
    • Gravity
    • Others
  • Intravenous Sets
  • IV Cannulas
  • Needleless Connectors

Application Insights:

  • Anti-Infective
  • Endocrinology
    • Diabetes
    • Others
  • Hydration Therapy
    • Athletes
    • Others
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan home infusion therapy market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan home infusion therapy market?
  • What is the breakup of the Japan home infusion therapy market on the basis of product?
  • What is the breakup of the Japan home infusion therapy market on the basis of application?
  • What are the various stages in the value chain of the Japan home infusion therapy market?
  • What are the key driving factors and challenges in the Japan home infusion therapy?
  • What is the structure of the Japan home infusion therapy market and who are the key players?
  • What is the degree of competition in the Japan home infusion therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Home Infusion Therapy Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Home Infusion Therapy Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Home Infusion Therapy Market - Breakup by Product

  • 6.1 Infusion Pumps
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Elastomeric
      • 6.1.3.2 Electromechanical
      • 6.1.3.3 Gravity
      • 6.1.3.4 Others
    • 6.1.4 Market Forecast (2025-2033)
  • 6.2 Intravenous Sets
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 IV Cannulas
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 Needleless Connectors
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)

7 Japan Home Infusion Therapy Market - Breakup by Application

  • 7.1 Anti-Infective
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Endocrinology
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Segmentation
      • 7.2.3.1 Diabetes
      • 7.2.3.2 Others
    • 7.2.4 Market Forecast (2025-2033)
  • 7.3 Hydration Therapy
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Segmentation
      • 7.3.3.1 Athletes
      • 7.3.3.2 Others
    • 7.3.4 Market Forecast (2025-2033)
  • 7.4 Chemotherapy
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2019-2024)
    • 7.4.3 Market Forecast (2025-2033)
  • 7.5 Enteral Nutrition
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2019-2024)
    • 7.5.3 Market Forecast (2025-2033)
  • 7.6 Parenteral Nutrition
    • 7.6.1 Overview
    • 7.6.2 Historical and Current Market Trends (2019-2024)
    • 7.6.3 Market Forecast (2025-2033)
  • 7.7 Specialty Pharmaceuticals
    • 7.7.1 Overview
    • 7.7.2 Historical and Current Market Trends (2019-2024)
    • 7.7.3 Market Forecast (2025-2033)
  • 7.8 Others
    • 7.8.1 Historical and Current Market Trends (2019-2024)
    • 7.8.2 Market Forecast (2025-2033)

8 Japan Home Infusion Therapy Market - Competitive Landscape

  • 8.1 Overview
  • 8.2 Market Structure
  • 8.3 Market Player Positioning
  • 8.4 Top Winning Strategies
  • 8.5 Competitive Dashboard
  • 8.6 Company Evaluation Quadrant

9 Profiles of Key Players

  • 9.1 Company A
    • 9.1.1 Business Overview
    • 9.1.2 Product Portfolio
    • 9.1.3 Business Strategies
    • 9.1.4 SWOT Analysis
    • 9.1.5 Major News and Events
  • 9.2 Company B
    • 9.2.1 Business Overview
    • 9.2.2 Product Portfolio
    • 9.2.3 Business Strategies
    • 9.2.4 SWOT Analysis
    • 9.2.5 Major News and Events
  • 9.3 Company C
    • 9.3.1 Business Overview
    • 9.3.2 Product Portfolio
    • 9.3.3 Business Strategies
    • 9.3.4 SWOT Analysis
    • 9.3.5 Major News and Events
  • 9.4 Company D
    • 9.4.1 Business Overview
    • 9.4.2 Product Portfolio
    • 9.4.3 Business Strategies
    • 9.4.4 SWOT Analysis
    • 9.4.5 Major News and Events
  • 9.5 Company E
    • 9.5.1 Business Overview
    • 9.5.2 Product Portfolio
    • 9.5.3 Business Strategies
    • 9.5.4 SWOT Analysis
    • 9.5.5 Major News and Events

10 Japan Home Infusion Therapy Market - Industry Analysis

  • 10.1 Drivers, Restraints, and Opportunities
    • 10.1.1 Overview
    • 10.1.2 Drivers
    • 10.1.3 Restraints
    • 10.1.4 Opportunities
  • 10.2 Porters Five Forces Analysis
    • 10.2.1 Overview
    • 10.2.2 Bargaining Power of Buyers
    • 10.2.3 Bargaining Power of Suppliers
    • 10.2.4 Degree of Competition
    • 10.2.5 Threat of New Entrants
    • 10.2.6 Threat of Substitutes
  • 10.3 Value Chain Analysis

11 Appendix